Search results for glaxosmithkline
GlaxoSmithKline (GSK) announced that it had gained approval from the European Commission for a new indication for use in children and infants of its
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline (GSK) and OncoMed Pharmaceuticals (OncoMed) today announced a worldwide strategic alliance to discover, develop and market novel anti
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline shot on to the FTSE 100 leaderboard after Berkshire Hathaway, Warren Buffett's vehicle, revealed in a US Securities and Exchange Commission filing that it had bought 1.51 million Ame
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
EUSA Pharma Inc ('EUSA'), a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has out-licensed the exclusive world-wide rig
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GSK announced significant new price reductions for its HIV medicines offered on a not-for-profit basis to the world's poorest countries. This reduction is the fifth time the company has made a price
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
alliConnect is GlaxoSmithKline's official corporate blog for alli, the only FDA-approved, OTC weight loss product. It's a place for you to have a conversation with us about weight loss issues. Beca
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Malaria is a devastating disease killing over one million people, mostly young children and pregnant women every year. There is an urgent need for new medicines to treat the disease as resistance bui
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline announced that the United States Food and Drug Administration (FDA) has granted Priority Review for Promacta®/Revolade® (eltrombopag) for the short-term treatment of patients with chr
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Glaxo provided the MHRA with data from clinical trials confirming that patients under 18 had a higher risk of suicidal behaviour if they were treated with Paxil, which is known as Seroxat in the UK,
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline (GSK) notes the conclusions announced today by the Medicines and Healthcare products Regulatory Agency (MHRA) regarding its investigation into disclosure of paediatric trial data for
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
